Clinical Trials Directory

Trials / Sponsors / PureTech

PureTech

Industry · 9 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With I
Idiopathic Pulmonary Fibrosis (IPF)
Phase 32026-04-01
CompletedStudy to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nin
Drug Interactions
Phase 12024-12-17
RecruitingA Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relaps
AML, Adult Recurrent, MDS
Phase 12022-12-12
Active Not RecruitingLYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 22022-07-22
CompletedLYT-300 in Healthy Volunteers
Healthy Volunteers
Phase 1 / Phase 22021-12-07
CompletedPK of Deupirfenidone Versus Pirfenidone in Older Healthy Subjects
Pharmacokinetic Analysis
Phase 12021-07-12
CompletedLYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metast
Metastatic Cancer, Solid Tumor, Pancreatic Cancer
Phase 1 / Phase 22020-12-15
TerminatedLYT-100 in Post-acute COVID-19 Respiratory Disease
Covid19, Post-acute COVID-19 Respiratory Disease
Phase 22020-12-11
TerminatedLYT-100 in Patients With BCRL
Breast Cancer Related Lymphoedema, Lymphoedema
Phase 22020-03-01